No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr19:51503600-51506400 |
Active TSS |
iPS-15b Cell Line |
embryonic stem cell
|
2 |
chr19:51503800-51506200 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
3 |
chr19:51504200-51506400 |
Active TSS |
ES-WA7 Cell Line |
embryonic stem cell
|
4 |
chr19:51504800-51506400 |
Active TSS |
ES-I3 Cell Line |
embryonic stem cell
|
5 |
chr19:51505200-51506200 |
Active TSS |
HUES6 Cell Line |
embryonic stem cell
|
6 |
chr19:51505400-51506400 |
Flanking Active TSS |
K562 |
blood
|
7 |
chr19:51505800-51506200 |
Bivalent Enhancer |
Placenta |
Placenta
|
8 |
chr19:51505800-51506200 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
9 |
chr19:51505800-51506400 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
10 |
chr19:51506000-51506200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
11 |
chr19:51506000-51506200 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
12 |
chr19:51506000-51506200 |
Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
13 |
chr19:51506000-51506200 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
14 |
chr19:51506000-51506200 |
Bivalent/Poised TSS |
A549 |
lung
|
15 |
chr19:51506000-51506400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
16 |
chr19:51506000-51506400 |
Enhancers |
HMEC |
breast
|
17 |
chr19:51506000-51506400 |
Enhancers |
NHEK |
skin
|
18 |
chr19:51506000-51507200 |
Genic enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
19 |
chr19:51506000-51509200 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
20 |
chr19:51506000-51509600 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|